These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7611285)

  • 1. Teaching about cystic fibrosis carrier screening by using written and video information.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
    Kai J; Ulph F; Cullinan T; Qureshi N
    Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
    Mennie ME; Compton ME; Gilfillan A; Liston WA; Pullen I; Whyte DA; Brock DJ
    J Med Genet; 1993 Jul; 30(7):543-8. PubMed ID: 8411025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involving consumers in the development of an educational program for cystic fibrosis carrier screening.
    Myers MF; Bernhardt BA; Tambor ES; Holtzman NA
    Am J Hum Genet; 1994 Apr; 54(4):719-26. PubMed ID: 8128971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educating patients about cystic fibrosis carrier screening in a primary care setting.
    Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Tambor ES; Holtzman NA
    Arch Fam Med; 1996 Jun; 5(6):336-40. PubMed ID: 8640323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
    Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Parental Understanding of Positive Newborn Screening Results and Carrier Status for Cystic Fibrosis with the use of a Short Educational Video.
    Temme R; Gruber A; Johnson M; Read L; Lu Y; McNamara J
    J Genet Couns; 2015 Jun; 24(3):473-81. PubMed ID: 25236483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet.
    Livingstone J; Axton RA; Mennie M; Gilfillan A; Brock DJ
    Clin Genet; 1993 Feb; 43(2):57-62. PubMed ID: 8448901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.